Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $211,413 - $276,691
-74,180 Closed
0 $0
Q4 2021

Sep 21, 2023

BUY
$3.24 - $5.18 $13,867 - $22,170
4,280 Added 6.12%
74,180 $249,000
Q4 2021

Feb 14, 2022

BUY
$3.24 - $5.18 $13,867 - $22,170
4,280 Added 6.12%
74,180 $250,000
Q3 2021

Sep 21, 2023

BUY
$3.94 - $5.84 $9,578 - $14,197
2,431 Added 3.6%
69,900 $356,000
Q3 2021

Nov 15, 2021

BUY
$3.94 - $5.84 $9,578 - $14,197
2,431 Added 3.6%
69,900 $356,000
Q2 2021

Sep 21, 2023

BUY
$4.26 - $6.5 $41,854 - $63,862
9,825 Added 17.04%
67,469 $295,000
Q2 2021

Aug 16, 2021

BUY
$4.26 - $6.5 $41,854 - $63,862
9,825 Added 17.04%
67,469 $296,000
Q1 2021

Sep 21, 2023

BUY
$5.03 - $8.8 $103,839 - $181,667
20,644 Added 55.79%
57,644 $357,000
Q1 2021

May 14, 2021

BUY
$5.03 - $8.8 $103,839 - $181,667
20,644 Added 55.79%
57,644 $358,000
Q4 2020

Sep 21, 2023

BUY
$4.04 - $5.31 $149,480 - $196,470
37,000 New
37,000 $180,000
Q4 2020

Feb 16, 2021

BUY
$4.04 - $5.31 $85,171 - $111,945
21,082 Added 132.44%
37,000 $181,000
Q3 2020

Nov 13, 2020

BUY
$3.64 - $7.76 $57,941 - $123,523
15,918 New
15,918 $67,000
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $859,549 - $1.49 Million
-179,822 Closed
0 $0
Q1 2020

Nov 24, 2020

BUY
$4.0 - $21.53 $719,288 - $3.87 Million
179,822 New
179,822 $2.44 Million
Q1 2020

May 15, 2020

SELL
$4.0 - $21.53 $26,476 - $142,507
-6,619 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$13.94 - $24.12 $186,531 - $322,749
-13,381 Reduced 66.91%
6,619 $142,000
Q3 2019

Nov 13, 2019

SELL
$13.89 - $23.16 $181,528 - $302,678
-13,069 Reduced 39.52%
20,000 $303,000
Q1 2019

May 15, 2019

BUY
$12.61 - $22.33 $414,478 - $733,964
32,869 Added 16434.5%
33,069 $687,000
Q4 2018

Feb 14, 2019

SELL
$12.41 - $22.98 $25.2 Million - $46.7 Million
-2,033,313 Reduced 99.99%
200 $3,000
Q3 2018

Nov 14, 2018

BUY
$2.45 - $16.27 $4.98 Million - $33.1 Million
2,033,513 New
2,033,513 $33.1 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.